Could a malaria drug help control friedreich ataxia? new trial explores
NCT ID NCT04921930
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study tested the drug artesunate (usually used for malaria) in 20 people with Friedreich ataxia, a rare genetic disease that affects movement and coordination. The goal was to find a safe dose that might help control the disease by improving how the body handles iron. The trial looked at side effects and a blood marker to decide the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre d'Investigation Clinique, hôpital Necker Enfants Malades
Paris, France
Conditions
Explore the condition pages connected to this study.